Page 39 - ITPS-7-3

INNOSC Theranostics and
Pharmacological Sciences Therapeutic value of terpenes

doi: 10.5650/jos.ess19294 doi: 10.3390/molecules25153361
360. Valdes M, Calzada F, Mendieta-Wejebe J. Structure-activity 370. Tan MJ, Ye JM, Turner N, et al. Antidiabetic activities
relationship study of acyclic terpenes in blood glucose levels: of triterpenoids isolated from bitter melon associated
Potential α-glucosidase and sodium glucose cotransporter with activation of the AMPK pathway. Chem Biol.
(SGLT-1) inhibitors. Molecules. 2019;24(22):4020. 2008;15(3):263-273.
doi: 10.3390/molecules24224020 doi: 10.1016/j.chembiol.2008.01.013
361. Sheikh BA, Pari L, Rathinam A, Chandramohan R. 371. Ye JM, Ruderman NB, Kraegen EW. AMP-activated
Trans-anethole, a terpenoid ameliorates hyperglycemia protein kinase and malonyl-CoA: Targets for treating
by regulating key enzymes of carbohydrate metabolism insulin resistance? Drug Discov Today Ther Strateg.
in streptozotocin induced diabetic rats. Biochimie. 2005;2(2):157-163.
2015;112:57-65.
doi: 10.1016/j.ddstr.2005.05.019
doi: 10.1016/j.biochi.2015.02.008
372. Iglesias MA, Ye JM, Frangioudakis G, et al. AICAR
362. Ying YM, Zhang LY, Zhang X, et al. Terpenoids with alpha- administration causes an apparent enhancement of muscle
glucosidase inhibitory activity from the submerged culture and liver insulin action in insulin-resistant high-fat-fed
of Inonotus obliquus. Phytochemistry. 2014;108:171-176. rats. Diabetes. 2002;51(10):2886-2894.
doi: 10.1016/j.phytochem.2014.09.022 doi: 10.2337/diabetes.51.10.2886
363. Chaudhary SC, Siddiqui MS, Athar M, Alam MS. 373. Research Paper. Paclitaxel Injection Market (By Indication:
D-Limonene modulates inflammation, oxidative stress and Prostate Cancer, Breast Cancer, Non-Small Cell Lung
Ras-ERK pathway to inhibit murine skin tumorigenesis. Cancer, AIDS Related Kaposi). Available from: https://www.
Hum Exp Toxicol. 2012;31(8):798-811. precedenceresearch.com/paclitaxel-injection-market [Last
doi: 10.1177/0960327111434948 accessed on 2023 Feb 07].
364. Bacanlı M, Anlar HG, Aydın S, et al. D-limonene ameliorates 374. Reports A. Terpenes Market Growing at CAGR 6.4% by Forecast
diabetes and its complications in streptozotocin-induced to 2022-2027. Top Players, Industry Size, Revenue and Share
diabetic rats. Food Chem Toxicol. 2017;110:434-442. Analysis. GlobeNewsWire. Available from: https://www.
globenewswire.com/news-release/2022/01/17/2367971/0/
doi: 10.1016/j.fct.2017.09.020 en/terpenes-market-growing-at-cagr-6-4-by-forecast-to-
365. Song BR, Alam MB, Lee SH. Terpenoid-rich extract of 2022-2027-top-players-industry-size-revenue-and-share-
Dillenia indica L. bark displays antidiabetic action in analysis-report-by-absolute-reports.html [Last accessed on
insulin-resistant C2C12 cells and STZ-induced diabetic 2023 Feb 07].
mice by attenuation of oxidative stress. Antioxidants (Basel). 375. Falotico R, Zhao JZ. Inventor; Injectable Formulation of
2022;11(7):1227. Paclitaxel for Cad Treatment. Patent applIcation 05253046.6;
doi: 10.3390/antiox11071227 2005.
366. Samarghandian S, Borji A, Delkhosh MB, Samini F. Safranal 376. Bowen ID, Ali AY. Inventor; Anti-tumour Terpene
treatment improves hyperglycemia, hyperlipidemia and Compounds. Patent Application PCT/GB2004/004769;
oxidative stress in streptozotocin-induced diabetic rats. 2005.
J Pharm Pharm Sci. 2013;16(2):352-362. 377. Myers CE, Trepel J, Sausville E, Samid D, Miller A, Curt,
doi: 10.18433/j3zs3q G. Inventor; Use of Monoterpenes, Sesquiterpernes and
Diterpernes for the Treatment of Cancer. Patent Application
367. El Midaoui A, Ghzaiel I, Vervandier-Fasseur D, et al. PCT/US1994/002340; 1994.
Saffron (Crocus sativus L.): A source of nutrients for health
and for the treatment of neuropsychiatric and age-related 378. Elson CE, Mo H. Inventor; Monoterpenoid Derivatives
diseases. Nutrients. 2022;14(3):597. for Treatment of Cancer. Patent Application PCT/
US1999/005082; 1999.
doi: 10.3390/nu14030597
379. Donksy M, Winnicki R. Inventor; Terpene and Cannabinoid
368. Centre TLD. SGLT1 Inhibitors. Available from: https://
londondiabetes.com/type-2/medication/sglt1-inhibitors Formulations. Patent Application PCT/IB2014/003156;
[Last accessed on 2023 Feb 07]. 2014.
380. Guynn JM. Inventor; Penetrating Topical Pain Relief
369. Valdés M, Calzada F, Mendieta-Wejebe JE, Merlín-Lucas V, Compositions and Methods of Use. Patent Application PCT/
Velázquez C, Barbosa E. Antihyperglycemic effects of
Annona diversifolia safford and its acyclic terpenoids: US2020/034984; 2020.
α-glucosidase and selective SGLT1 inhibitiors. Molecules. 381. Knudsen CL. Inventor; Device with Compositions for
2020;25(15):3361. Delivery to the Lungs, the Oral Mucosa and the Brain. Patent

Volume 7 Issue 3 (2024) 30 doi: 10.36922/itps.0332